Pulmonary REsistance Modification Under Treatment With Sacubitril/valsartaN in paTients With Heart Failure With Reduced Ejection Fraction
Condition:   Heart Failure Interventions:   Drug: Sacubitril-valsartan;   Drug: Enalapril;   Drug: placebo;   Drug: Placebo Sponsors:   Clinical Hospital Heliodor Swiecicki of the Medical University of Karol Marcinkowski in Poznań;   Medical Research Agency, Poland;   Medical University of Bialystok;   University of Opole;   Medical University of Gdańsk;   Medical University of Silesia Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 4, 2022 Category: Research Source Type: clinical trials

Continuing or Discontinuing ACE/ARBs in Patients With Chronic Kidney Disease Undergoing Coronary Angiography
Conditions:   Contrast-induced Nephropathy;   Chronic Kidney Diseases;   Ischemic Heart Disease Interventions:   Other: Continue ACEI or ARBs ( Enalapril , Ramipril , Valsartan , Candesartan, Losartan );   Other: Hold ACEI or ARBs Sponsor:   An-Najah National University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 9, 2022 Category: Research Source Type: clinical trials